Do You Suffer from Persistent Runny Nose and Nasal Congestion?

These symptoms may indicate Chronic Rhinitis. The PARAGON study is evaluating the NEUROMARK Rhinitis Neurolysis Therapy® in for the treatment of Chronic Rhinitis and these symptoms. You may be eligible to participate in a clinical trial and help make an impact on chronic rhinitis treatment.

About Study Participation

Individuals may qualify to participate in the PARAGON study if they:

  • Are 18 years of age or older.
  • Have chronic rhinitis as diagnosed by your physician.
  • Have moderate to severe symptoms of runny nose and stuffy nose.
  • Have not had other surgeries to treat chronic rhinitis.

Please take our survey below to see if you qualify.

About The Treatment

Neurent Medical’s proprietary Rhinitis Neurolysis Therapy™ is an investigational in-office treatment option for chronic allergic and non-allergic rhinitis. Using a gentle and flexible hand-held device and local anaesthetic, your ENT physician will access and treat hyperactive parasympathetic nerves inside your nasal passages that cause the core symptoms of congestion and rhinorrhea (runny nose).

  • In-office treatment using only a local anaesthetic
  • The treatment is designed so there is a return to normal activities immediately after the procedure
  • The procedure has been well tolerated using local anesthetic6

Chronic Rhinitis

  • Chronic rhinitis is inflammation and swelling of tissues inside the nose that results in symptoms such as congestion and rhinorrhea (runny nose), sneezing and nasal itching.
  • Chronic rhinitis is known to significantly decrease quality of life. Chronic rhinitis can have an adverse effect on a patient’s sleep quality, mood, and daily activities. It’s also known to decrease productivity at work, school and during sports, leading to millions of lost work and school days per year.
  • It is estimated that 1 in 4 Americans suffer from rhinitis.
  1. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy lmmunol. 2007;19:23-34. PMID: 17153005.
  2. Kalmarzi, R. N., Khazaei, Z., Shahsavar, J., Gharibi, F., Tavakol, M., Khazaei, S., & Shariat, M. (2017).
  3. The impact of allergic rhinitis on quality of life: A study in western Iran. Biomedical Research and Therapy, 4(9), 1629. doi:10.15419/bmrat.v4i9.370
  4. Craig, T., et al. (2004). The correlation between allergic rhinitis and sleep disturbance.Journal of Allergy and Clinical Immunology, 114. doi:10.1016/j.jaci.2004.08.044
  5. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28:3-9.
  6. RELIEVE Final Clinical Report CLP-001